DexCom, Inc. DXCM
86.62
(0.85)
(0.97%)
as of 25 Sep
- Market cap
- $33.0B
- P/E
- 33.4×
Follow DXCM
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
DexCom, Inc. (DXCM) P/E ratio
As of 25 September 2026, DexCom, Inc. (DXCM) trades at a P/E ratio of 33.4×. Over the past ten years it has ranged from 0.0× (December 2019) to 311× (November 2018); the current reading is higher than 46% of that period. That is above the Medical Devices industry median of 22.2× and above the Healthcare sector median of 22.7×.
P/E ratio, daily
Annual
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 30.9× | (41.65%) |
| FY2024 | 52.9× | (39.40%) |
| FY2023 | 87.3× | (33.04%) |
| FY2022 | 130× | (53.62%) |
| FY2021 | 281× | 292.28% |
| FY2020 | 71.7× | (64.30%) |
| FY2019 | 201× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
| FY2016 | 0.0× | — |
Quarterly
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 26.0× | (0.62%) |
| Mar 2026 | 26.2× | (15.24%) |
| Dec 2025 | 30.9× | (15.13%) |
| Sep 2025 | 36.4× | (39.16%) |
| 42 more quarters | Free account |
Against its own ten years
Low 0.0×
High 311×
Ten-year median
40.1×
Current reading's percentile
46
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| GEHC GE HealthCare Technologies Inc. compare | 15.3× |
| BSX Boston Scientific Corporation compare | 17.7× |
| PHG Koninklijke Philips N.V. compare | 18.2× |
| ZBH Zimmer Biomet Holdings, Inc. compare | 22.0× |
| STE STERIS plc compare | 25.4× |
| SNN Smith & Nephew SNATS, Inc. compare | 32.8× |
| DXCM DexCom, Inc. | 33.4× |
| EW Edwards Lifesciences Corporation compare | 49.6× |
| PEN Penumbra, Inc. compare | 78.0× |
| Medical Devices industry median | 22.2× |
| Healthcare sector median | 22.7× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on DXCM
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement